Cargando…
Venous obstruction of thyroid malignancy origin: the Antoine Lacassagne Institute experience
BACKGROUND AND AIMS: To show the benefits of Ultrasonography in the diagnosis of great vein involvement in the neck and mediastinum in thyroid malignancies (primary or secondary) in our experience and to report patient outcomes. METHODS: Clinical data were collected from the thyroid unit database of...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2674443/ https://www.ncbi.nlm.nih.gov/pubmed/19374744 http://dx.doi.org/10.1186/1477-7819-7-40 |
_version_ | 1782166638058012672 |
---|---|
author | Marcy, Pierre-Yves René Thariat, Juliet Bozec, Alex Poissonnet, Gilles Benisvy, Danielle Dassonville, Olivier |
author_facet | Marcy, Pierre-Yves René Thariat, Juliet Bozec, Alex Poissonnet, Gilles Benisvy, Danielle Dassonville, Olivier |
author_sort | Marcy, Pierre-Yves René |
collection | PubMed |
description | BACKGROUND AND AIMS: To show the benefits of Ultrasonography in the diagnosis of great vein involvement in the neck and mediastinum in thyroid malignancies (primary or secondary) in our experience and to report patient outcomes. METHODS: Clinical data were collected from the thyroid unit database of the Antoine Lacassagne Institute. RESULTS: Of 1171 patients with thyroid cancer treated at our institution over the last 18 years, we retrospectively identified nine patients (0.8%), three women and six men, aged 34–81 years (median age: 70 years) presenting with malignant thyroid tumor of median diameter 45 mm (range: 23–87) having venous obstruction of thyroid malignancy origin. Two patients underwent multimodal therapy. All other patients underwent external beam radiation therapy alone ± chemotherapy or palliative care. Ultrasound (US) provided particularly useful information on venous involvement characteristics. Median survival was 7 months and median progression-free survival was 6 months. Survival in our series was worse than that of previously reported series despite diagnosis of vein involvement at an early stage in 2/3 cases using US. CONCLUSION: Despite small numbers of patients, it seems that aggressive treatment modalities including surgery are required to improve survival. In our experience, US was a useful non-invasive method to describe tumor extensions to great veins of the neck (invasion versus compression, tumor thrombus versus blood clot) and should be recommended to depict early venous invasion in cases of suspected thyroid malignancy. |
format | Text |
id | pubmed-2674443 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-26744432009-04-29 Venous obstruction of thyroid malignancy origin: the Antoine Lacassagne Institute experience Marcy, Pierre-Yves René Thariat, Juliet Bozec, Alex Poissonnet, Gilles Benisvy, Danielle Dassonville, Olivier World J Surg Oncol Research BACKGROUND AND AIMS: To show the benefits of Ultrasonography in the diagnosis of great vein involvement in the neck and mediastinum in thyroid malignancies (primary or secondary) in our experience and to report patient outcomes. METHODS: Clinical data were collected from the thyroid unit database of the Antoine Lacassagne Institute. RESULTS: Of 1171 patients with thyroid cancer treated at our institution over the last 18 years, we retrospectively identified nine patients (0.8%), three women and six men, aged 34–81 years (median age: 70 years) presenting with malignant thyroid tumor of median diameter 45 mm (range: 23–87) having venous obstruction of thyroid malignancy origin. Two patients underwent multimodal therapy. All other patients underwent external beam radiation therapy alone ± chemotherapy or palliative care. Ultrasound (US) provided particularly useful information on venous involvement characteristics. Median survival was 7 months and median progression-free survival was 6 months. Survival in our series was worse than that of previously reported series despite diagnosis of vein involvement at an early stage in 2/3 cases using US. CONCLUSION: Despite small numbers of patients, it seems that aggressive treatment modalities including surgery are required to improve survival. In our experience, US was a useful non-invasive method to describe tumor extensions to great veins of the neck (invasion versus compression, tumor thrombus versus blood clot) and should be recommended to depict early venous invasion in cases of suspected thyroid malignancy. BioMed Central 2009-04-17 /pmc/articles/PMC2674443/ /pubmed/19374744 http://dx.doi.org/10.1186/1477-7819-7-40 Text en Copyright © 2009 Marcy et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Marcy, Pierre-Yves René Thariat, Juliet Bozec, Alex Poissonnet, Gilles Benisvy, Danielle Dassonville, Olivier Venous obstruction of thyroid malignancy origin: the Antoine Lacassagne Institute experience |
title | Venous obstruction of thyroid malignancy origin: the Antoine Lacassagne Institute experience |
title_full | Venous obstruction of thyroid malignancy origin: the Antoine Lacassagne Institute experience |
title_fullStr | Venous obstruction of thyroid malignancy origin: the Antoine Lacassagne Institute experience |
title_full_unstemmed | Venous obstruction of thyroid malignancy origin: the Antoine Lacassagne Institute experience |
title_short | Venous obstruction of thyroid malignancy origin: the Antoine Lacassagne Institute experience |
title_sort | venous obstruction of thyroid malignancy origin: the antoine lacassagne institute experience |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2674443/ https://www.ncbi.nlm.nih.gov/pubmed/19374744 http://dx.doi.org/10.1186/1477-7819-7-40 |
work_keys_str_mv | AT marcypierreyvesrene venousobstructionofthyroidmalignancyorigintheantoinelacassagneinstituteexperience AT thariatjuliet venousobstructionofthyroidmalignancyorigintheantoinelacassagneinstituteexperience AT bozecalex venousobstructionofthyroidmalignancyorigintheantoinelacassagneinstituteexperience AT poissonnetgilles venousobstructionofthyroidmalignancyorigintheantoinelacassagneinstituteexperience AT benisvydanielle venousobstructionofthyroidmalignancyorigintheantoinelacassagneinstituteexperience AT dassonvilleolivier venousobstructionofthyroidmalignancyorigintheantoinelacassagneinstituteexperience |